Literature DB >> 11179675

Modulation of the promoter region of prepro-hypocretin by alpha-interferon.

N S Waleh1, A Apte-Deshpande, A Terao, J Ding, T S Kilduff.   

Abstract

Hypocretins 1 and 2 (also called orexins A and B, respectively) are hypothalamic neuropeptides that have recently been shown to be involved in the sleep disorder narcolepsy and possibly in the normal regulation of sleep and wake functions. These two peptides are derived from a single precursor molecule called prepro-hypocretin, also known as prepro-orexin. We have cloned a 450 bp fragment from the 5'-flanking region of the human prepro-hypocretin gene and demonstrated that this fragment has promoter activity in vitro. Deletions at the 5' end from -450 to -188 reduced the promoter activity by approximately 50%. Further deletion from the 5'-end to -69 almost completely abolished promoter activity. The 450 bp fragment contains a number of potential transcription factor binding sites, including an interferon (IFN) response element. Our studies demonstrate that alpha-IFN strongly inhibits the promoter activity of both 450 and 188 bp fragments in a dose-dependent manner. The inhibitory effect of alpha-IFN is consistent with recent studies which suggest that hypocretin 1/orexin A may be involved in modulating arousal states and with the literature indicating involvement of immune-related molecules in sleep regulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179675     DOI: 10.1016/s0378-1119(00)00544-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  5 in total

1.  Tissue specificity of methylation and expression of human genes coding for neuropeptides and their receptors, and of a human endogenous retrovirus K family.

Authors:  Hong-Mei Shen; Akifumi Nakamura; Jun Sugimoto; Noboru Sakumoto; Takaya Oda; Yoshihiro Jinno; Yuji Okazaki
Journal:  J Hum Genet       Date:  2006-03-17       Impact factor: 3.172

2.  Identification of differentially expressed genes in blood cells of narcolepsy patients.

Authors:  Susumu Tanaka; Yutaka Honda; Makoto Honda
Journal:  Sleep       Date:  2007-08       Impact factor: 5.849

3.  Modular organization of a hypocretin gene minimal promoter.

Authors:  Adriana Sánchez-García; Griselda A Cabral-Pacheco; Viviana C Zomosa-Signoret; Rocío Ortiz-López; Alberto Camacho; Paulo M Tabera-Tarello; José A Garnica-López; Román Vidaltamayo
Journal:  Mol Med Rep       Date:  2017-11-22       Impact factor: 2.952

4.  The evolutionarily conserved miRNA-137 targets the neuropeptide hypocretin/orexin and modulates the wake to sleep ratio.

Authors:  Anja Holm; Marie-Laure Possovre; Mojtaba Bandarabadi; Kristine F Moseholm; Jessica L Justinussen; Ivan Bozic; René Lemcke; Yoan Arribat; Francesca Amati; Asli Silahtaroglu; Maxime Juventin; Antoine Adamantidis; Mehdi Tafti; Birgitte R Kornum
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-22       Impact factor: 12.779

5.  Identification of a set of genes showing regionally enriched expression in the mouse brain.

Authors:  Cletus A D'Souza; Vikramjit Chopra; Richard Varhol; Yuan-Yun Xie; Slavita Bohacec; Yongjun Zhao; Lisa L C Lee; Mikhail Bilenky; Elodie Portales-Casamar; An He; Wyeth W Wasserman; Daniel Goldowitz; Marco A Marra; Robert A Holt; Elizabeth M Simpson; Steven J M Jones
Journal:  BMC Neurosci       Date:  2008-07-14       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.